- Home
- AVDL vs HUYA Comparison
AVDL vs HUYA Comparison
Compare AVDL & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- HUYA
- Stock Information
- Founded
- AVDL 2015
- HUYA 2014
- Country
- AVDL Ireland
- HUYA China
- Employees
- AVDL N/A
- HUYA N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- HUYA Computer Software: Programming Data Processing
- Sector
- AVDL Health Care
- HUYA Technology
- Exchange
- AVDL Nasdaq
- HUYA Nasdaq
- Market Cap
- AVDL 784.6M
- HUYA 754.5M
- IPO Year
- AVDL 1996
- HUYA 2018
- Fundamental
- Price
- AVDL $9.18
- HUYA $3.67
- Analyst Decision
- AVDL Strong Buy
- HUYA Buy
- Analyst Count
- AVDL 6
- HUYA 3
- Target Price
- AVDL $18.17
- HUYA $4.57
- AVG Volume (30 Days)
- AVDL 1.3M
- HUYA 1.5M
- Earning Date
- AVDL 08-07-2025
- HUYA 08-12-2025
- Dividend Yield
- AVDL N/A
- HUYA 69.29%
- EPS Growth
- AVDL N/A
- HUYA N/A
- EPS
- AVDL N/A
- HUYA N/A
- Revenue
- AVDL $194,450,000.00
- HUYA $838,372,907.00
- Revenue This Year
- AVDL $56.88
- HUYA $5.82
- Revenue Next Year
- AVDL $29.81
- HUYA $4.20
- P/E Ratio
- AVDL N/A
- HUYA N/A
- Revenue Growth
- AVDL 252.64
- HUYA N/A
- 52 Week Low
- AVDL $6.38
- HUYA $2.82
- 52 Week High
- AVDL $17.30
- HUYA $6.43
- Technical
- Relative Strength Index (RSI)
- AVDL 47.63
- HUYA 43.01
- Support Level
- AVDL $9.10
- HUYA $3.86
- Resistance Level
- AVDL $9.76
- HUYA $4.15
- Average True Range (ATR)
- AVDL 0.47
- HUYA 0.14
- MACD
- AVDL -0.08
- HUYA -0.04
- Stochastic Oscillator
- AVDL 14.29
- HUYA 8.57
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
About HUYA HUYA Inc. American depositary shares each representing one ordinary share
Established in 2011, Huya is the largest online game livestreaming company in China. Headquartered in Guangzhou, Huya mainly provides livestreamed videos on esports games such as League of Legends and Honor of Kings and collects virtual tips from viewers. Its products include the Huya Live platform in China and Nimo TV in Southeast Asia and South America. As of 2023, Huya was a subsidiary of Tencent, which owned 63% of its equity stake and held 94% of the voting power.